News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mauna Kea Technologies Announces Strong Presence at Asia-Pacific Digestive Week / World Congress of Gastroenterology 2013



9/19/2013 6:35:54 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Regulatory News:

Mauna Kea Technologies (NYSE Euronext: MKEA, FR0010609263), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, today announced a strong presence at the joint Asia-Pacific Digestive Week / World Congress of Gastroenterology (APDW/WCOG) 2013. 13 presentations will highlight the use of Optical Biopsy across many of the most pervasive diseases in the gastrointestinal tract.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES